{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:40:08Z","timestamp":1783248008101,"version":"3.54.6"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pharmthera.2023.108388","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T18:39:01Z","timestamp":1679337541000},"page":"108388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Review: Sex-related differences in the treatment of cardiac arrhythmia"],"prefix":"10.1016","volume":"244","author":[{"given":"Magda","family":"Haum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kellnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Thienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbinian","family":"Lackermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pharmthera.2023.108388_bb0005","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European heart rhythm association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108388_bb0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/01.CIR.93.6.1170","article-title":"Sex differences in cardiac arrest survivors","volume":"93","author":"Albert","year":"1996","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jacep.2018.01.014","article-title":"Comparing management and outcomes in men and women with nonvalvular atrial fibrillation: Data from a population-based cohort","volume":"4","author":"Arnson","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"39","key":"10.1016\/j.pharmthera.2023.108388_bb0020","first-page":"2733","article-title":"ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force, M","year":"2014","journal-title":"Eur Heart J, 2014."},{"key":"10.1016\/j.pharmthera.2023.108388_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2021.04.011","article-title":"Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity","volume":"203","author":"Avarello","year":"2021","journal-title":"Thrombosis Research"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108388_bb0030","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/jama.2012.3490","article-title":"Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation","volume":"307","author":"Avgil Tsadok","year":"2012","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108388_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/heartjnl-2016-310850","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: A review and meta-analysis","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108388_bb0045","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2008.07.052","article-title":"Gender differences in clinical manifestations of Brugada syndrome","volume":"52","author":"Benito","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0050","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","article-title":"Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation","volume":"12","author":"Bhave","year":"2015","journal-title":"Heart Rhythm"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108388_bb0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002398","article-title":"Lifetime risk for sudden cardiac death in the community","volume":"5","author":"Bogle","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0070","first-page":"163","article-title":"Atrioventricular nodal reentrant tachycardia: Anatomical and electrophysiological considerations","volume":"4","author":"Bulava","year":"2003","journal-title":"Italian Heart Journal"},{"issue":"47","key":"10.1016\/j.pharmthera.2023.108388_bb0075","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/eurheartj\/ehz837","article-title":"The 2019 ESC guidelines for the Management of Patients with supraventricular tachycardia","volume":"40","author":"Calkins","year":"2019","journal-title":"European Heart Journal"},{"issue":"36","key":"10.1016\/j.pharmthera.2023.108388_bb0080","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/ehz151","article-title":"Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: The United States Nationwide readmissions database 2010-14","volume":"40","author":"Cheung","year":"2019","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108388_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108388_bb0090","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMc1701400","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0095","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1111\/bcp.14892","article-title":"Sex-influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta-analysis","volume":"87","author":"Costa Viana","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108388_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.644279","article-title":"The Link between sex hormones and susceptibility to cardiac arrhythmias: From molecular basis to clinical implications","volume":"8","author":"Costa","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2006.10.047","article-title":"Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the euro heart survey on atrial fibrillation","volume":"49","author":"Dagres","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108388_bb0110","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.CIR.0000032002.22105.7A","article-title":"Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males","volume":"106","author":"Di Diego","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108388_bb0115","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jce.15078","article-title":"Gender associated disparities in atrioventricular nodal reentrant tachycardia: A review article","volume":"32","author":"Etaee","year":"2021","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0120","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/europace\/euu130","article-title":"Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: Results from Patients\u2019 perspective on radiofrequency catheter ablation of AVRT and AVNRT study","volume":"16","author":"Farkowski","year":"2014","journal-title":"Europace"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108388_bb0125","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jacc.2016.02.062","article-title":"Etiology of sudden death in sports: Insights from a United Kingdom regional registry","volume":"67","author":"Finocchiaro","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108388_bb0130","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/heartjnl-2019-314881","article-title":"Association of sex and atrial fibrillation therapies with patient-reported outcomes","volume":"105","author":"Gleason","year":"2019","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017267","article-title":"Impact of medical castration on malignant arrhythmias in patients with prostate Cancer","volume":"10","author":"Hasegawa","year":"2021","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0140","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/CIRCRESAHA.116.304521","article-title":"The spectrum of epidemiology underlying sudden cardiac death","volume":"116","author":"Hayashi","year":"2015","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1145","article-title":"Assessment of sex differences in the initial symptom burden, applied treatment strategy, and quality of life in Japanese patients with atrial fibrillation","volume":"2","author":"Ikemura","year":"2019","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108388_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1542-474X.2004.94580.x","article-title":"Estrogen and progestin use and the QT interval in postmenopausal women","volume":"9","author":"Kadish","year":"2004","journal-title":"Annals of Noninvasive Electrocardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108388_bb0160","first-page":"1065","article-title":"Sex differences in the biology and pathology of the aging heart","volume":"32","author":"Keller","year":"2016","journal-title":"The Canadian Journal of Cardiology"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108388_bb0165","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/eurheartj\/ehy731","article-title":"Risk stratification for stroke in atrial fibrillation: A critique","volume":"40","author":"Killu","year":"2019","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108388_bb0170","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108388_bb0175","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"The New England Journal of Medicine"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108388_bb0180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0002-9149(98)00868-6","article-title":"JTc prolongation with d,l-sotalol in women versus men","volume":"83","author":"Lehmann","year":"1999","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0190","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archinte.1997.00440260085013","article-title":"Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder","volume":"157","author":"Lessmeier","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2023.108388_bb0195","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.12659\/MSM.919366","article-title":"Sex differences in presentation, quality of life, and treatment in Chinese atrial fibrillation patients: Insights from the China atrial fibrillation registry study","volume":"25","author":"Li","year":"2019","journal-title":"Medical Science Monitor"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108388_bb0200","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/europace\/euy067","article-title":"Sex differences in cardiac arrhythmia: A consensus document of the European heart rhythm association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society","volume":"20","author":"Linde","year":"2018","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108388_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/europace\/euu155","article-title":"Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the euro observational research Programme pilot survey on atrial fibrillation","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0210","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjcard.2005.08.042","article-title":"Gender-related differences in patients with atrioventricular nodal reentry tachycardia","volume":"97","author":"Liuba","year":"2006","journal-title":"The American Journal of Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0215","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: A report from the north American ARVC registry","volume":"54","author":"Marcus","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108388_bb0220","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: Proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2009.08.050","article-title":"Cardiac action potential duration and calcium regulation in males and females","volume":"388","author":"Mason","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7 Pt 1","key":"10.1016\/j.pharmthera.2023.108388_bb0235","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1046\/j.1460-9592.2003.t01-1-00227.x","article-title":"Disappearance of the Brugada-type electrocardiogram after surgical castration: A role for testosterone and an explanation for the male preponderance","volume":"26","author":"Matsuo","year":"2003","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108388_bb0240","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.hrthm.2018.06.019","article-title":"Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients","volume":"15","author":"Milman","year":"2018","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"The New England Journal of Medicine"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108388_bb0250","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108388_bb0255","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0260","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1540-8167.2002.00633.x","article-title":"Gender differences in various types of idiopathic ventricular tachycardia","volume":"13","author":"Nakagawa","year":"2002","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108388_bb0265","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1540-8159.2006.00407.x","article-title":"Influence of menstrual cycle on QT interval dynamics","volume":"29","author":"Nakagawa","year":"2006","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108388_bb0270","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/euje.4.1.36","article-title":"Effect of age and sex on left atrial morphology and function","volume":"4","author":"Nikitin","year":"2003","journal-title":"European Journal of Echocardiography"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0275","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1253\/circj.CJ-11-0442","article-title":"Gender differences in idiopathic ventricular arrhythmias","volume":"75","author":"Nogami","year":"2011","journal-title":"Circulation Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108388_bb0280","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jelectrocard.2014.07.015","article-title":"Pilot study of sex differences in QTc intervals of heart transplant recipients","volume":"47","author":"Novotny","year":"2014","journal-title":"Journal of Electrocardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0285","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"25","key":"10.1016\/j.pharmthera.2023.108388_bb0290","first-page":"e533","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108388_bb0295","article-title":"Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation","volume":"14","author":"O'Neal","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108388_bb0300","first-page":"789","article-title":"Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish diet, cancer and health study","volume":"112","author":"Overvad","year":"2014","journal-title":"Thrombosis and Haemostasis"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108388_bb0305","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0310","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9149(00)01077-8","article-title":"Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation","volume":"86","author":"Paquette","year":"2000","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0315","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00424-013-1233-0","article-title":"Sex differences in mechanisms of cardiac excitation-contraction coupling","volume":"465","author":"Parks","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108388_bb0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.crd.0000096416.94304.bd","article-title":"The influence of gender on arrhythmias","volume":"12","author":"Peters","year":"2004","journal-title":"Cardiology in Review"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0325","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0008-6363(01)00429-1","article-title":"Sex, hormones, and repolarization","volume":"53","author":"Pham","year":"2002","journal-title":"Cardiovascular Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108388_bb0330","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11239-021-02482-8","article-title":"Stroke risk factors and outcomes among hospitalized women with atrial fibrillation","volume":"52","author":"Piazza","year":"2021","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0335","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamacardio.2016.0529","article-title":"Differences in clinical and functional outcomes of atrial fibrillation in women and men: Two-year results from the ORBIT-AF registry","volume":"1","author":"Piccini","year":"2016","journal-title":"JAMA Cardiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108388_bb0340","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hrthm.2018.01.027","article-title":"Dofetilide dose reductions and discontinuations in women compared with men","volume":"15","author":"Pokorney","year":"2018","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108388_bb0345","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail, 2016."},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108388_bb0350","first-page":"1601","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"issue":"41","key":"10.1016\/j.pharmthera.2023.108388_bb0355","first-page":"2793","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J, 2015."},{"issue":"23","key":"10.1016\/j.pharmthera.2023.108388_bb0360","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: Impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0365","first-page":"690","article-title":"Sex differences in the evolution of the electrocardiographic QT interval with age","volume":"8","author":"Rautaharju","year":"1992","journal-title":"The Canadian Journal of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0370","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jelectrocard.2010.11.009","article-title":"Electrocardiographic estimates of action potential durations and transmural repolarization time gradients in healthy subjects and in acute coronary syndrome patients--profound differences by sex and by presence vs absence of diagnostic ST elevation","volume":"44","author":"Rautaharju","year":"2011","journal-title":"Journal of Electrocardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0375","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2005.05.078","article-title":"Gender-related differences in rhythm control treatment in persistent atrial fibrillation: Data of the rate control versus electrical cardioversion (RACE) study","volume":"46","author":"Rienstra","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108388_bb0380","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circulation. Cardiovascular Genetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108388_bb0385","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/HCO.0b013e328333f95f","article-title":"Sex differences in arrhythmias","volume":"25","author":"Rivero","year":"2010","journal-title":"Current Opinion in Cardiology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108388_bb0390","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.285.10.1322","article-title":"Drug-induced QT prolongation in women during the menstrual cycle","volume":"285","author":"Rodriguez","year":"2001","journal-title":"JAMA"},{"issue":"9921","key":"10.1016\/j.pharmthera.2023.108388_bb0395","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108388_bb0400","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.015910","article-title":"Disparities in the management of newly diagnosed paroxysmal supraventricular tachycardia for women versus men in the United States","volume":"9","author":"Sacks","year":"2020","journal-title":"Journal of the American Heart Association"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108388_bb0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0410","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.hrthm.2014.04.010","article-title":"A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: Validation of the 2013 diagnostic criteria","volume":"11","author":"Savastano","year":"2014","journal-title":"Heart Rhythm"},{"issue":"9989","key":"10.1016\/j.pharmthera.2023.108388_bb0415","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: A cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0420","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00059-005-2724-3","article-title":"Gender differences in cardiac arrhythmias","volume":"30","author":"Schulze-Bahr","year":"2005","journal-title":"Herz"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0425","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108388_bb0430","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/heartjnl-2015-308556","article-title":"Clinical characterisation and long-term prognosis of women with Brugada syndrome","volume":"102","author":"Sieira","year":"2016","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108388_bb0435","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025779","article-title":"Sex-based differences in 30-day readmissions after cardiac arrest: Analysis of the Nationwide readmissions database","volume":"11","author":"Sobti","year":"2022","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108388_bb0440","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1074248411406505","article-title":"Gender differences in cardiac repolarization following intravenous sotalol administration","volume":"17","author":"Somberg","year":"2012","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108388_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106718","article-title":"Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019","volume":"115","author":"Sosinsky","year":"2022","journal-title":"Contemporary Clinical Trials"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108388_bb0450","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCEP.113.001034","article-title":"Public health burden of sudden cardiac death in the United States","volume":"7","author":"Stecker","year":"2014","journal-title":"Circulation. Arrhythmia and Electrophysiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0455","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.amjcard.2012.08.014","article-title":"Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM)","volume":"110","author":"Sullivan","year":"2012","journal-title":"The American Journal of Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108388_bb0460","first-page":"783","article-title":"Sex differences in cardiac electrophysiology and clinical arrhythmias: Epidemiology, therapeutics, and mechanisms","volume":"30","author":"Tadros","year":"2014","journal-title":"The Canadian Journal of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108388_bb0465","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108388_bb0470","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12265-019-09918-w","article-title":"Gender differences in arrhythmias: Focused on atrial fibrillation","volume":"13","author":"Tian","year":"2020","journal-title":"Journal of Cardiovascular Translational Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108388_bb0475","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: Essentials for clinicians","volume":"29","author":"Trinkley","year":"2013","journal-title":"Current Medical Research and Opinion"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108388_bb0480","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108388_bb0485","first-page":"265","article-title":"Gender and cardiac arrhythmias","volume":"28","author":"Villareal","year":"2001","journal-title":"Texas Heart Institute Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108388_bb0490","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1111\/jce.14838","article-title":"Women and atrial fibrillation","volume":"32","author":"Volgman","year":"2021","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108388_bb0495","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/europace\/euy295","article-title":"Sex differences in rate and rhythm control for atrial fibrillation","volume":"21","author":"Webernd\u00f6rfer","year":"2019","journal-title":"Europace"},{"issue":"10092","key":"10.1016\/j.pharmthera.2023.108388_bb0500","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108388_bb0505","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573403X15666181205110624","article-title":"Gender differences in atrial fibrillation: A review of epidemiology, management, and outcomes","volume":"15","author":"Westerman","year":"2019","journal-title":"Current Cardiology Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108388_bb0510","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/hrt.2004.046334","article-title":"Genetics of cardiac arrhythmias","volume":"91","author":"Wilde","year":"2005","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108388_bb0515","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00001573-199901000-00007","article-title":"Arrhythmias and women","volume":"14","author":"Wolbrette","year":"1999","journal-title":"Current Opinion in Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108388_bb0520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/clc.4950250203","article-title":"Gender differences in arrhythmias","volume":"25","author":"Wolbrette","year":"2002","journal-title":"Clinical Cardiology"},{"issue":"23","key":"10.1016\/j.pharmthera.2023.108388_bb0525","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"The New England Journal of Medicine"},{"issue":"Suppl. 4","key":"10.1016\/j.pharmthera.2023.108388_bb0530","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.33549\/physiolres.932920","article-title":"Gender differences in electrophysiological characteristics of idiopathic ventricular tachycardia originating from right ventricular outflow tract","volume":"63","author":"Yang","year":"2014","journal-title":"Physiological Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108388_bb0535","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCRESAHA.121.319893","article-title":"Arrhythmias in female patients: Incidence","volume":"130","author":"Zeitler","year":"2022","journal-title":"Presentation and Management. Circ Res"},{"issue":"40","key":"10.1016\/j.pharmthera.2023.108388_bb0540","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"European Heart Journal"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:32:20Z","timestamp":1759012340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":108,"alternative-id":["S0163725823000529"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108388","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Sex-related differences in the treatment of cardiac arrhythmia","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108388"}}